Cognition Therapeutics Plans Phase 3 for Alzheimer’s Drug
Clinical Trial Vanguard
By: Jon Napitupulu
December 3, 2025
Cognition Therapeutics Plans Phase 3 for Alzheimer’s Drug Read More »
Cognition Therapeutics and FDA Align on Zervimesine Trial for Alzheimer’s
Clinical Trial Vanguard
By: Jon Napitupulu
August 14, 2025
Cognition Therapeutics and FDA Align on Zervimesine Trial for Alzheimer’s Read More »
Cognition Therapeutics’ drug shows 129% cognitive decline arrest in mild Alzheimer’s
Clinical Trials Arena
By Abigail Beaney
July 30, 2025
New Data: Zervimesine for the Treatment of Dementia with Lewy Bodies and Alzheimer Disease
Psychiatric Times
By Leah Kuntz
July 29, 2025
Zervimesine for the Treatment of Dementia With Lewy Bodies and Alzheimer Disease Read More »
Cognition Therapeutics Wraps Up FDA Review, Moves Closer to Phase 3 Alzheimer’s Trial
Prism Marketview
By Alex Corbit
July 10, 2025
Cognition Therapeutics Wraps Up FDA Review, Moves Closer to Phase 3 Alzheimer’s Trial Read More »
Cognition Therapeutics assumes no responsibility for the content of third-party website. Neither does Cognition control, endorse or guarantee any aspect of your use of third-party sites. We encourage you to read and evaluate terms of use, privacy and other policies of the destination site as they may differ from Cognition’s policies.
Cognition Therapeutics assumes no responsibility for the content of third-party website. Neither does Cognition control, endorse or guarantee any aspect of your use of third-party sites. We encourage you to read and evaluate terms of use, privacy and other policies of the destination site as they may differ from Cognition’s policies.
Cognition Therapeutics assumes no responsibility for the content of third-party website. Neither does Cognition control, endorse or guarantee any aspect of your use of third-party sites. We encourage you to read and evaluate terms of use, privacy and other policies of the destination site as they may differ from Cognition’s policies.
Cognition Therapeutics assumes no responsibility for the content of third-party website. Neither does Cognition control, endorse or guarantee any aspect of your use of third-party sites. We encourage you to read and evaluate terms of use, privacy and other policies of the destination site as they may differ from Cognition’s policies.
Cognition Therapeutics assumes no responsibility for the content of third-party website. Neither does Cognition control, endorse or guarantee any aspect of your use of third-party sites. We encourage you to read and evaluate terms of use, privacy and other policies of the destination site as they may differ from Cognition’s policies.
